Conclusions: Infliximab improved clinical outcomes compared to the previous use of intravenous cyclosporine in patients admitted with steroid-refractory acute severe UC. In 2006, infliximab was ...
Adding a 4-week course of cyclosporine to antiretroviral therapy did not improve immunologic or virologic response. During acute and early HIV infection, high levels of viremia generate a massive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback